Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Percutaneous implantation of the CoreValve self-expanding aortic valve prosthesis in patients with severe aortic stenosis: early experience in Spain.

Avanzas P, Muñoz-García AJ, Segura J, Pan M, Alonso-Briales JH, Lozano I, Morís C, Suárez de Lezo J, Hernández-García JM.

Rev Esp Cardiol. 2010 Feb;63(2):141-8. English, Spanish.

2.

Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.

Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A, Wenaweser P, Sauren B, Mohr FW, Walther T, Zickmann B, Iversen S, Felderhoff T, Cartier R, Bonan R.

J Am Coll Cardiol. 2007 Jul 3;50(1):69-76. Epub 2007 Jun 6.

3.

Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study.

Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, Mueller R, Menichelli M, Schmidt T, Zickmann B, Iversen S, Stone GW.

Circulation. 2006 Oct 10;114(15):1616-24. Epub 2006 Oct 2.

4.

Transcatheter aortic valve implantation: 3-year outcomes of self-expanding CoreValve prosthesis.

Ussia GP, Barbanti M, Petronio AS, Tarantini G, Ettori F, Colombo A, Violini R, Ramondo A, Santoro G, Klugmann S, Bedogni F, Maisano F, Marzocchi A, Poli A, De Carlo M, Napodano M, Fiorina C, De Marco F, Antoniucci D, de Cillis E, Capodanno D, Tamburino C; CoreValve Italian Registry Investigators.

Eur Heart J. 2012 Apr;33(8):969-76. doi: 10.1093/eurheartj/ehr491. Epub 2012 Jan 12.

5.

Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system.

Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, Beucher H, Felderhoff T, Iversen S, Gerckens U.

Circ Cardiovasc Interv. 2008 Dec;1(3):167-75. doi: 10.1161/CIRCINTERVENTIONS.108.819839.

6.

Alternative approaches for trans-catheter self-expanding aortic bioprosthetic valves implantation: single-center experience.

Bruschi G, De Marco F, Fratto P, Oreglia J, Colombo P, Botta L, Klugmann S, Martinelli L.

Eur J Cardiothorac Surg. 2011 Jun;39(6):e151-8. doi: 10.1016/j.ejcts.2011.01.014. Epub 2011 Mar 2.

PMID:
21371900
7.

Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.

Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J; German Transcatheter Aortic Valve Interventions-Registry Investigators.

Eur Heart J. 2011 Jan;32(2):198-204. doi: 10.1093/eurheartj/ehq339. Epub 2010 Sep 23.

8.

Transapical transcatheter aortic valve implantation using the JenaValve™ system: acute and 30-day results of the multicentre CE-mark study.

Treede H, Mohr FW, Baldus S, Rastan A, Ensminger S, Arnold M, Kempfert J, Figulla HR.

Eur J Cardiothorac Surg. 2012 Jun;41(6):e131-8. doi: 10.1093/ejcts/ezs129. Epub 2012 Apr 16.

PMID:
22508111
9.

Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) corevalve revalving system: results from the multicentre, expanded evaluation registry 1-year following CE mark approval.

Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde JC, de Jaegere P, Serruys PW.

EuroIntervention. 2008 Aug;4(2):242-9.

PMID:
19110790
10.

Impact of patient-prosthesis mismatch after transcatheter aortic valve-in-valve implantation in degenerated bioprostheses.

Seiffert M, Conradi L, Baldus S, Knap M, Schirmer J, Franzen O, Koschyk D, Meinertz T, Reichenspurner H, Treede H.

J Thorac Cardiovasc Surg. 2012 Mar;143(3):617-24. doi: 10.1016/j.jtcvs.2011.11.004. Epub 2011 Dec 9.

11.

Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry.

Eltchaninoff H, Prat A, Gilard M, Leguerrier A, Blanchard D, Fournial G, Iung B, Donzeau-Gouge P, Tribouilloy C, Debrux JL, Pavie A, Gueret P; FRANCE Registry Investigators.

Eur Heart J. 2011 Jan;32(2):191-7. doi: 10.1093/eurheartj/ehq261. Epub 2010 Sep 15.

12.

Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis.

Tamburino C, Capodanno D, Mulè M, Scarabelli M, Cammalleri V, Barbanti M, Calafiore A, Ussia G.

J Invasive Cardiol. 2009 Mar;21(3):93-8.

13.

Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study.

Schofer J, Schlüter M, Treede H, Franzen OW, Tübler T, Pascotto A, Low RI, Bolling SF, Meinertz T, Reichenspurner H.

Circ Cardiovasc Interv. 2008 Oct;1(2):126-33. doi: 10.1161/CIRCINTERVENTIONS.108.800607. Epub 2008 Sep 3.

14.

Transcatheter aortic valve implantation: safety and effectiveness of the treatment of degenerated aortic homograft.

López-Otero D, Teles R, Gómez-Hospital JA, Balestrini CS, Romaguera R, Saaibi-Solano JF, Neves J, Cid-Alvarez B, Brito J, Cequier-Fillat A, Trillo-Nouche R.

Rev Esp Cardiol (Engl Ed). 2012 Apr;65(4):350-5. doi: 10.1016/j.recesp.2011.11.019. Epub 2012 Feb 15.

PMID:
22341955
15.

The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results.

Muñoz-García AJ, del Valle R, Trillo-Nouche R, Elízaga J, Gimeno F, Hernández-Antolín R, Teles R, de Gama Ribeiro V, Molina E, Cequier A, Urbano-Carrillo C, Cruz-González I, Payaslian M, Patricio L, Sztejfman M, Iñiguez A, Rodríguez V, Scuteri A, Caorsi C, López-Otero D, Avanzas P, Alonso-Briales JH, Hernández-García JM, Morís C; Ibero-American registry investigators.

Int J Cardiol. 2013 Nov 20;169(5):359-65. doi: 10.1016/j.ijcard.2013.09.006. Epub 2013 Oct 4.

PMID:
24128731
16.

Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients.

Bleiziffer S, Mazzitelli D, Opitz A, Hettich I, Ruge H, Piazza N, Lange R.

J Thorac Cardiovasc Surg. 2012 Feb;143(2):310-7. doi: 10.1016/j.jtcvs.2011.10.060. Epub 2011 Dec 3.

17.

Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team.

Bleiziffer S, Ruge H, Mazzitelli D, Schreiber C, Hutter A, Laborde JC, Bauernschmitt R, Lange R.

Eur J Cardiothorac Surg. 2009 Apr;35(4):615-20; discussion 620-1. doi: 10.1016/j.ejcts.2008.12.041. Epub 2009 Feb 23.

PMID:
19233669
18.

The trans-subclavian retrograde approach for transcatheter aortic valve replacement: single-center experience.

Bruschi G, Fratto P, De Marco F, Oreglia J, Colombo P, Botta L, Cannata A, Moreo A, De Chiara B, Lullo F, Paino R, Martinelli L, Klugmann S.

J Thorac Cardiovasc Surg. 2010 Oct;140(4):911-5, 915.e1-2. doi: 10.1016/j.jtcvs.2010.01.027.

19.

[Transcatheter aortic valve implantation (TAVI)TAVI): A new therapeutic option for patients with severe symptomatic aortic stenosis who are not suitable or at high risk for surgical valve replacement].

Zahn R, Schiele R, Kilkowski C, Klein B, Schwarz AK, Zeymer U, Lehmann A, Cornelius B, Horack M, Saggau W, Werling C.

Dtsch Med Wochenschr. 2010 Aug;135(33):1589-95. doi: 10.1055/s-0030-1262450. Epub 2010 Aug 17. German.

PMID:
20717862
20.

Survival and predictive factors of mortality after 30 days in patients treated with percutaneous implantation of the CoreValve aortic prosthesis.

Muñoz-García AJ, Hernández-García JM, Jiménez-Navarro MF, Alonso-Briales JH, Domínguez-Franco AJ, Rodríguez-Bailón I, Molina-Mora MJ, Hernández-Rodríguez P, Such-Martínez M, de Teresa-Galván E.

Am Heart J. 2012 Feb;163(2):288-94. doi: 10.1016/j.ahj.2011.11.013.

PMID:
22305849
Items per page

Supplemental Content

Write to the Help Desk